Metoclopramide Market, Global Outlook and Forecast 2022-2028
Metoclopramide is a medication used mostly for stomach and esophageal problems. It is commonly used to treat and prevent nausea and vomiting, to help with emptying of the stomach in people with delayed stomach emptying, and to help with gastroesophageal reflux disease. It is also used to treat migraine headaches.
This report contains market size and forecasts of Metoclopramide in global, including the following market information:
Global Metoclopramide Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Metoclopramide Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Metoclopramide companies in 2021 (%)
The global Metoclopramide market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Metoclopramide include Teva, Sanofi, Astellas, Adwya, Biofarma, Apotex, Novartis, ASKA Seiyaku Asuka and Yang Sheng, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Metoclopramide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Metoclopramide Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Metoclopramide Market Segment Percentages, by Type, 2021 (%)
Global Metoclopramide Market Segment Percentages, by Application, 2021 (%)
Global Metoclopramide Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Metoclopramide revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Metoclopramide revenues share in global market, 2021 (%)
Key companies Metoclopramide sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Metoclopramide sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Metoclopramide in global, including the following market information:
Global Metoclopramide Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Metoclopramide Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Metoclopramide companies in 2021 (%)
The global Metoclopramide market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Metoclopramide include Teva, Sanofi, Astellas, Adwya, Biofarma, Apotex, Novartis, ASKA Seiyaku Asuka and Yang Sheng, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Metoclopramide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Metoclopramide Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Metoclopramide Market Segment Percentages, by Type, 2021 (%)
- Oral
- Injection
Global Metoclopramide Market Segment Percentages, by Application, 2021 (%)
- Nausea
- Migraine
- Gastroparesis
Global Metoclopramide Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Metoclopramide revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Metoclopramide revenues share in global market, 2021 (%)
Key companies Metoclopramide sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Metoclopramide sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Teva
- Sanofi
- Astellas
- Adwya
- Biofarma
- Apotex
- Novartis
- ASKA Seiyaku Asuka
- Yang Sheng
- Meda Pharma
- Johnson and Johnson
- GSK
- Alkaloid Pharmaceuticals
- Teuto Brasileiro
- Mylan
- EU-Pharma
- Le Vet
- Omega Laboratories
- Orion Pharma
- Pfizer
- Wockhardt
- Amneal Pharmaceuticals
- Nidda
- Ceva Sante Animale
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Metoclopramide Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Metoclopramide Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL METOCLOPRAMIDE OVERALL MARKET SIZE
2.1 Global Metoclopramide Market Size: 2021 VS 2028
2.2 Global Metoclopramide Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Metoclopramide Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Metoclopramide Players in Global Market
3.2 Top Global Metoclopramide Companies Ranked by Revenue
3.3 Global Metoclopramide Revenue by Companies
3.4 Global Metoclopramide Sales by Companies
3.5 Global Metoclopramide Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Metoclopramide Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Metoclopramide Product Type
3.8 Tier 1, Tier 2 and Tier 3 Metoclopramide Players in Global Market
3.8.1 List of Global Tier 1 Metoclopramide Companies
3.8.2 List of Global Tier 2 and Tier 3 Metoclopramide Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Metoclopramide Market Size Markets, 2021 & 2028
4.1.2 Oral
4.1.3 Injection
4.2 By Type - Global Metoclopramide Revenue & Forecasts
4.2.1 By Type - Global Metoclopramide Revenue, 2017-2022
4.2.2 By Type - Global Metoclopramide Revenue, 2023-2028
4.2.3 By Type - Global Metoclopramide Revenue Market Share, 2017-2028
4.3 By Type - Global Metoclopramide Sales & Forecasts
4.3.1 By Type - Global Metoclopramide Sales, 2017-2022
4.3.2 By Type - Global Metoclopramide Sales, 2023-2028
4.3.3 By Type - Global Metoclopramide Sales Market Share, 2017-2028
4.4 By Type - Global Metoclopramide Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Metoclopramide Market Size, 2021 & 2028
5.1.2 Nausea
5.1.3 Migraine
5.1.4 Gastroparesis
5.2 By Application - Global Metoclopramide Revenue & Forecasts
5.2.1 By Application - Global Metoclopramide Revenue, 2017-2022
5.2.2 By Application - Global Metoclopramide Revenue, 2023-2028
5.2.3 By Application - Global Metoclopramide Revenue Market Share, 2017-2028
5.3 By Application - Global Metoclopramide Sales & Forecasts
5.3.1 By Application - Global Metoclopramide Sales, 2017-2022
5.3.2 By Application - Global Metoclopramide Sales, 2023-2028
5.3.3 By Application - Global Metoclopramide Sales Market Share, 2017-2028
5.4 By Application - Global Metoclopramide Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Metoclopramide Market Size, 2021 & 2028
6.2 By Region - Global Metoclopramide Revenue & Forecasts
6.2.1 By Region - Global Metoclopramide Revenue, 2017-2022
6.2.2 By Region - Global Metoclopramide Revenue, 2023-2028
6.2.3 By Region - Global Metoclopramide Revenue Market Share, 2017-2028
6.3 By Region - Global Metoclopramide Sales & Forecasts
6.3.1 By Region - Global Metoclopramide Sales, 2017-2022
6.3.2 By Region - Global Metoclopramide Sales, 2023-2028
6.3.3 By Region - Global Metoclopramide Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Metoclopramide Revenue, 2017-2028
6.4.2 By Country - North America Metoclopramide Sales, 2017-2028
6.4.3 US Metoclopramide Market Size, 2017-2028
6.4.4 Canada Metoclopramide Market Size, 2017-2028
6.4.5 Mexico Metoclopramide Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Metoclopramide Revenue, 2017-2028
6.5.2 By Country - Europe Metoclopramide Sales, 2017-2028
6.5.3 Germany Metoclopramide Market Size, 2017-2028
6.5.4 France Metoclopramide Market Size, 2017-2028
6.5.5 U.K. Metoclopramide Market Size, 2017-2028
6.5.6 Italy Metoclopramide Market Size, 2017-2028
6.5.7 Russia Metoclopramide Market Size, 2017-2028
6.5.8 Nordic Countries Metoclopramide Market Size, 2017-2028
6.5.9 Benelux Metoclopramide Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Metoclopramide Revenue, 2017-2028
6.6.2 By Region - Asia Metoclopramide Sales, 2017-2028
6.6.3 China Metoclopramide Market Size, 2017-2028
6.6.4 Japan Metoclopramide Market Size, 2017-2028
6.6.5 South Korea Metoclopramide Market Size, 2017-2028
6.6.6 Southeast Asia Metoclopramide Market Size, 2017-2028
6.6.7 India Metoclopramide Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Metoclopramide Revenue, 2017-2028
6.7.2 By Country - South America Metoclopramide Sales, 2017-2028
6.7.3 Brazil Metoclopramide Market Size, 2017-2028
6.7.4 Argentina Metoclopramide Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Metoclopramide Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Metoclopramide Sales, 2017-2028
6.8.3 Turkey Metoclopramide Market Size, 2017-2028
6.8.4 Israel Metoclopramide Market Size, 2017-2028
6.8.5 Saudi Arabia Metoclopramide Market Size, 2017-2028
6.8.6 UAE Metoclopramide Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Teva
7.1.1 Teva Corporate Summary
7.1.2 Teva Business Overview
7.1.3 Teva Metoclopramide Major Product Offerings
7.1.4 Teva Metoclopramide Sales and Revenue in Global (2017-2022)
7.1.5 Teva Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Metoclopramide Major Product Offerings
7.2.4 Sanofi Metoclopramide Sales and Revenue in Global (2017-2022)
7.2.5 Sanofi Key News
7.3 Astellas
7.3.1 Astellas Corporate Summary
7.3.2 Astellas Business Overview
7.3.3 Astellas Metoclopramide Major Product Offerings
7.3.4 Astellas Metoclopramide Sales and Revenue in Global (2017-2022)
7.3.5 Astellas Key News
7.4 Adwya
7.4.1 Adwya Corporate Summary
7.4.2 Adwya Business Overview
7.4.3 Adwya Metoclopramide Major Product Offerings
7.4.4 Adwya Metoclopramide Sales and Revenue in Global (2017-2022)
7.4.5 Adwya Key News
7.5 Biofarma
7.5.1 Biofarma Corporate Summary
7.5.2 Biofarma Business Overview
7.5.3 Biofarma Metoclopramide Major Product Offerings
7.5.4 Biofarma Metoclopramide Sales and Revenue in Global (2017-2022)
7.5.5 Biofarma Key News
7.6 Apotex
7.6.1 Apotex Corporate Summary
7.6.2 Apotex Business Overview
7.6.3 Apotex Metoclopramide Major Product Offerings
7.6.4 Apotex Metoclopramide Sales and Revenue in Global (2017-2022)
7.6.5 Apotex Key News
7.7 Novartis
7.7.1 Novartis Corporate Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Metoclopramide Major Product Offerings
7.7.4 Novartis Metoclopramide Sales and Revenue in Global (2017-2022)
7.7.5 Novartis Key News
7.8 ASKA Seiyaku Asuka
7.8.1 ASKA Seiyaku Asuka Corporate Summary
7.8.2 ASKA Seiyaku Asuka Business Overview
7.8.3 ASKA Seiyaku Asuka Metoclopramide Major Product Offerings
7.8.4 ASKA Seiyaku Asuka Metoclopramide Sales and Revenue in Global (2017-2022)
7.8.5 ASKA Seiyaku Asuka Key News
7.9 Yang Sheng
7.9.1 Yang Sheng Corporate Summary
7.9.2 Yang Sheng Business Overview
7.9.3 Yang Sheng Metoclopramide Major Product Offerings
7.9.4 Yang Sheng Metoclopramide Sales and Revenue in Global (2017-2022)
7.9.5 Yang Sheng Key News
7.10 Meda Pharma
7.10.1 Meda Pharma Corporate Summary
7.10.2 Meda Pharma Business Overview
7.10.3 Meda Pharma Metoclopramide Major Product Offerings
7.10.4 Meda Pharma Metoclopramide Sales and Revenue in Global (2017-2022)
7.10.5 Meda Pharma Key News
7.11 Johnson and Johnson
7.11.1 Johnson and Johnson Corporate Summary
7.11.2 Johnson and Johnson Metoclopramide Business Overview
7.11.3 Johnson and Johnson Metoclopramide Major Product Offerings
7.11.4 Johnson and Johnson Metoclopramide Sales and Revenue in Global (2017-2022)
7.11.5 Johnson and Johnson Key News
7.12 GSK
7.12.1 GSK Corporate Summary
7.12.2 GSK Metoclopramide Business Overview
7.12.3 GSK Metoclopramide Major Product Offerings
7.12.4 GSK Metoclopramide Sales and Revenue in Global (2017-2022)
7.12.5 GSK Key News
7.13 Alkaloid Pharmaceuticals
7.13.1 Alkaloid Pharmaceuticals Corporate Summary
7.13.2 Alkaloid Pharmaceuticals Metoclopramide Business Overview
7.13.3 Alkaloid Pharmaceuticals Metoclopramide Major Product Offerings
7.13.4 Alkaloid Pharmaceuticals Metoclopramide Sales and Revenue in Global (2017-2022)
7.13.5 Alkaloid Pharmaceuticals Key News
7.14 Teuto Brasileiro
7.14.1 Teuto Brasileiro Corporate Summary
7.14.2 Teuto Brasileiro Business Overview
7.14.3 Teuto Brasileiro Metoclopramide Major Product Offerings
7.14.4 Teuto Brasileiro Metoclopramide Sales and Revenue in Global (2017-2022)
7.14.5 Teuto Brasileiro Key News
7.15 Mylan
7.15.1 Mylan Corporate Summary
7.15.2 Mylan Business Overview
7.15.3 Mylan Metoclopramide Major Product Offerings
7.15.4 Mylan Metoclopramide Sales and Revenue in Global (2017-2022)
7.15.5 Mylan Key News
7.16 EU-Pharma
7.16.1 EU-Pharma Corporate Summary
7.16.2 EU-Pharma Business Overview
7.16.3 EU-Pharma Metoclopramide Major Product Offerings
7.16.4 EU-Pharma Metoclopramide Sales and Revenue in Global (2017-2022)
7.16.5 EU-Pharma Key News
7.17 Le Vet
7.17.1 Le Vet Corporate Summary
7.17.2 Le Vet Business Overview
7.17.3 Le Vet Metoclopramide Major Product Offerings
7.17.4 Le Vet Metoclopramide Sales and Revenue in Global (2017-2022)
7.17.5 Le Vet Key News
7.18 Omega Laboratories
7.18.1 Omega Laboratories Corporate Summary
7.18.2 Omega Laboratories Business Overview
7.18.3 Omega Laboratories Metoclopramide Major Product Offerings
7.18.4 Omega Laboratories Metoclopramide Sales and Revenue in Global (2017-2022)
7.18.5 Omega Laboratories Key News
7.19 Orion Pharma
7.19.1 Orion Pharma Corporate Summary
7.19.2 Orion Pharma Business Overview
7.19.3 Orion Pharma Metoclopramide Major Product Offerings
7.19.4 Orion Pharma Metoclopramide Sales and Revenue in Global (2017-2022)
7.19.5 Orion Pharma Key News
7.20 Pfizer
7.20.1 Pfizer Corporate Summary
7.20.2 Pfizer Business Overview
7.20.3 Pfizer Metoclopramide Major Product Offerings
7.20.4 Pfizer Metoclopramide Sales and Revenue in Global (2017-2022)
7.20.5 Pfizer Key News
7.21 Wockhardt
7.21.1 Wockhardt Corporate Summary
7.21.2 Wockhardt Business Overview
7.21.3 Wockhardt Metoclopramide Major Product Offerings
7.21.4 Wockhardt Metoclopramide Sales and Revenue in Global (2017-2022)
7.21.5 Wockhardt Key News
7.22 Amneal Pharmaceuticals
7.22.1 Amneal Pharmaceuticals Corporate Summary
7.22.2 Amneal Pharmaceuticals Business Overview
7.22.3 Amneal Pharmaceuticals Metoclopramide Major Product Offerings
7.22.4 Amneal Pharmaceuticals Metoclopramide Sales and Revenue in Global (2017-2022)
7.22.5 Amneal Pharmaceuticals Key News
7.23 Nidda
7.23.1 Nidda Corporate Summary
7.23.2 Nidda Business Overview
7.23.3 Nidda Metoclopramide Major Product Offerings
7.23.4 Nidda Metoclopramide Sales and Revenue in Global (2017-2022)
7.23.5 Nidda Key News
7.24 Ceva Sante Animale
7.24.1 Ceva Sante Animale Corporate Summary
7.24.2 Ceva Sante Animale Business Overview
7.24.3 Ceva Sante Animale Metoclopramide Major Product Offerings
7.24.4 Ceva Sante Animale Metoclopramide Sales and Revenue in Global (2017-2022)
7.24.5 Ceva Sante Animale Key News
8 GLOBAL METOCLOPRAMIDE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Metoclopramide Production Capacity, 2017-2028
8.2 Metoclopramide Production Capacity of Key Manufacturers in Global Market
8.3 Global Metoclopramide Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 METOCLOPRAMIDE SUPPLY CHAIN ANALYSIS
10.1 Metoclopramide Industry Value Chain
10.2 Metoclopramide Upstream Market
10.3 Metoclopramide Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Metoclopramide Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Metoclopramide Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Metoclopramide Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL METOCLOPRAMIDE OVERALL MARKET SIZE
2.1 Global Metoclopramide Market Size: 2021 VS 2028
2.2 Global Metoclopramide Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Metoclopramide Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Metoclopramide Players in Global Market
3.2 Top Global Metoclopramide Companies Ranked by Revenue
3.3 Global Metoclopramide Revenue by Companies
3.4 Global Metoclopramide Sales by Companies
3.5 Global Metoclopramide Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Metoclopramide Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Metoclopramide Product Type
3.8 Tier 1, Tier 2 and Tier 3 Metoclopramide Players in Global Market
3.8.1 List of Global Tier 1 Metoclopramide Companies
3.8.2 List of Global Tier 2 and Tier 3 Metoclopramide Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Metoclopramide Market Size Markets, 2021 & 2028
4.1.2 Oral
4.1.3 Injection
4.2 By Type - Global Metoclopramide Revenue & Forecasts
4.2.1 By Type - Global Metoclopramide Revenue, 2017-2022
4.2.2 By Type - Global Metoclopramide Revenue, 2023-2028
4.2.3 By Type - Global Metoclopramide Revenue Market Share, 2017-2028
4.3 By Type - Global Metoclopramide Sales & Forecasts
4.3.1 By Type - Global Metoclopramide Sales, 2017-2022
4.3.2 By Type - Global Metoclopramide Sales, 2023-2028
4.3.3 By Type - Global Metoclopramide Sales Market Share, 2017-2028
4.4 By Type - Global Metoclopramide Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Metoclopramide Market Size, 2021 & 2028
5.1.2 Nausea
5.1.3 Migraine
5.1.4 Gastroparesis
5.2 By Application - Global Metoclopramide Revenue & Forecasts
5.2.1 By Application - Global Metoclopramide Revenue, 2017-2022
5.2.2 By Application - Global Metoclopramide Revenue, 2023-2028
5.2.3 By Application - Global Metoclopramide Revenue Market Share, 2017-2028
5.3 By Application - Global Metoclopramide Sales & Forecasts
5.3.1 By Application - Global Metoclopramide Sales, 2017-2022
5.3.2 By Application - Global Metoclopramide Sales, 2023-2028
5.3.3 By Application - Global Metoclopramide Sales Market Share, 2017-2028
5.4 By Application - Global Metoclopramide Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Metoclopramide Market Size, 2021 & 2028
6.2 By Region - Global Metoclopramide Revenue & Forecasts
6.2.1 By Region - Global Metoclopramide Revenue, 2017-2022
6.2.2 By Region - Global Metoclopramide Revenue, 2023-2028
6.2.3 By Region - Global Metoclopramide Revenue Market Share, 2017-2028
6.3 By Region - Global Metoclopramide Sales & Forecasts
6.3.1 By Region - Global Metoclopramide Sales, 2017-2022
6.3.2 By Region - Global Metoclopramide Sales, 2023-2028
6.3.3 By Region - Global Metoclopramide Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Metoclopramide Revenue, 2017-2028
6.4.2 By Country - North America Metoclopramide Sales, 2017-2028
6.4.3 US Metoclopramide Market Size, 2017-2028
6.4.4 Canada Metoclopramide Market Size, 2017-2028
6.4.5 Mexico Metoclopramide Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Metoclopramide Revenue, 2017-2028
6.5.2 By Country - Europe Metoclopramide Sales, 2017-2028
6.5.3 Germany Metoclopramide Market Size, 2017-2028
6.5.4 France Metoclopramide Market Size, 2017-2028
6.5.5 U.K. Metoclopramide Market Size, 2017-2028
6.5.6 Italy Metoclopramide Market Size, 2017-2028
6.5.7 Russia Metoclopramide Market Size, 2017-2028
6.5.8 Nordic Countries Metoclopramide Market Size, 2017-2028
6.5.9 Benelux Metoclopramide Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Metoclopramide Revenue, 2017-2028
6.6.2 By Region - Asia Metoclopramide Sales, 2017-2028
6.6.3 China Metoclopramide Market Size, 2017-2028
6.6.4 Japan Metoclopramide Market Size, 2017-2028
6.6.5 South Korea Metoclopramide Market Size, 2017-2028
6.6.6 Southeast Asia Metoclopramide Market Size, 2017-2028
6.6.7 India Metoclopramide Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Metoclopramide Revenue, 2017-2028
6.7.2 By Country - South America Metoclopramide Sales, 2017-2028
6.7.3 Brazil Metoclopramide Market Size, 2017-2028
6.7.4 Argentina Metoclopramide Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Metoclopramide Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Metoclopramide Sales, 2017-2028
6.8.3 Turkey Metoclopramide Market Size, 2017-2028
6.8.4 Israel Metoclopramide Market Size, 2017-2028
6.8.5 Saudi Arabia Metoclopramide Market Size, 2017-2028
6.8.6 UAE Metoclopramide Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Teva
7.1.1 Teva Corporate Summary
7.1.2 Teva Business Overview
7.1.3 Teva Metoclopramide Major Product Offerings
7.1.4 Teva Metoclopramide Sales and Revenue in Global (2017-2022)
7.1.5 Teva Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Metoclopramide Major Product Offerings
7.2.4 Sanofi Metoclopramide Sales and Revenue in Global (2017-2022)
7.2.5 Sanofi Key News
7.3 Astellas
7.3.1 Astellas Corporate Summary
7.3.2 Astellas Business Overview
7.3.3 Astellas Metoclopramide Major Product Offerings
7.3.4 Astellas Metoclopramide Sales and Revenue in Global (2017-2022)
7.3.5 Astellas Key News
7.4 Adwya
7.4.1 Adwya Corporate Summary
7.4.2 Adwya Business Overview
7.4.3 Adwya Metoclopramide Major Product Offerings
7.4.4 Adwya Metoclopramide Sales and Revenue in Global (2017-2022)
7.4.5 Adwya Key News
7.5 Biofarma
7.5.1 Biofarma Corporate Summary
7.5.2 Biofarma Business Overview
7.5.3 Biofarma Metoclopramide Major Product Offerings
7.5.4 Biofarma Metoclopramide Sales and Revenue in Global (2017-2022)
7.5.5 Biofarma Key News
7.6 Apotex
7.6.1 Apotex Corporate Summary
7.6.2 Apotex Business Overview
7.6.3 Apotex Metoclopramide Major Product Offerings
7.6.4 Apotex Metoclopramide Sales and Revenue in Global (2017-2022)
7.6.5 Apotex Key News
7.7 Novartis
7.7.1 Novartis Corporate Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Metoclopramide Major Product Offerings
7.7.4 Novartis Metoclopramide Sales and Revenue in Global (2017-2022)
7.7.5 Novartis Key News
7.8 ASKA Seiyaku Asuka
7.8.1 ASKA Seiyaku Asuka Corporate Summary
7.8.2 ASKA Seiyaku Asuka Business Overview
7.8.3 ASKA Seiyaku Asuka Metoclopramide Major Product Offerings
7.8.4 ASKA Seiyaku Asuka Metoclopramide Sales and Revenue in Global (2017-2022)
7.8.5 ASKA Seiyaku Asuka Key News
7.9 Yang Sheng
7.9.1 Yang Sheng Corporate Summary
7.9.2 Yang Sheng Business Overview
7.9.3 Yang Sheng Metoclopramide Major Product Offerings
7.9.4 Yang Sheng Metoclopramide Sales and Revenue in Global (2017-2022)
7.9.5 Yang Sheng Key News
7.10 Meda Pharma
7.10.1 Meda Pharma Corporate Summary
7.10.2 Meda Pharma Business Overview
7.10.3 Meda Pharma Metoclopramide Major Product Offerings
7.10.4 Meda Pharma Metoclopramide Sales and Revenue in Global (2017-2022)
7.10.5 Meda Pharma Key News
7.11 Johnson and Johnson
7.11.1 Johnson and Johnson Corporate Summary
7.11.2 Johnson and Johnson Metoclopramide Business Overview
7.11.3 Johnson and Johnson Metoclopramide Major Product Offerings
7.11.4 Johnson and Johnson Metoclopramide Sales and Revenue in Global (2017-2022)
7.11.5 Johnson and Johnson Key News
7.12 GSK
7.12.1 GSK Corporate Summary
7.12.2 GSK Metoclopramide Business Overview
7.12.3 GSK Metoclopramide Major Product Offerings
7.12.4 GSK Metoclopramide Sales and Revenue in Global (2017-2022)
7.12.5 GSK Key News
7.13 Alkaloid Pharmaceuticals
7.13.1 Alkaloid Pharmaceuticals Corporate Summary
7.13.2 Alkaloid Pharmaceuticals Metoclopramide Business Overview
7.13.3 Alkaloid Pharmaceuticals Metoclopramide Major Product Offerings
7.13.4 Alkaloid Pharmaceuticals Metoclopramide Sales and Revenue in Global (2017-2022)
7.13.5 Alkaloid Pharmaceuticals Key News
7.14 Teuto Brasileiro
7.14.1 Teuto Brasileiro Corporate Summary
7.14.2 Teuto Brasileiro Business Overview
7.14.3 Teuto Brasileiro Metoclopramide Major Product Offerings
7.14.4 Teuto Brasileiro Metoclopramide Sales and Revenue in Global (2017-2022)
7.14.5 Teuto Brasileiro Key News
7.15 Mylan
7.15.1 Mylan Corporate Summary
7.15.2 Mylan Business Overview
7.15.3 Mylan Metoclopramide Major Product Offerings
7.15.4 Mylan Metoclopramide Sales and Revenue in Global (2017-2022)
7.15.5 Mylan Key News
7.16 EU-Pharma
7.16.1 EU-Pharma Corporate Summary
7.16.2 EU-Pharma Business Overview
7.16.3 EU-Pharma Metoclopramide Major Product Offerings
7.16.4 EU-Pharma Metoclopramide Sales and Revenue in Global (2017-2022)
7.16.5 EU-Pharma Key News
7.17 Le Vet
7.17.1 Le Vet Corporate Summary
7.17.2 Le Vet Business Overview
7.17.3 Le Vet Metoclopramide Major Product Offerings
7.17.4 Le Vet Metoclopramide Sales and Revenue in Global (2017-2022)
7.17.5 Le Vet Key News
7.18 Omega Laboratories
7.18.1 Omega Laboratories Corporate Summary
7.18.2 Omega Laboratories Business Overview
7.18.3 Omega Laboratories Metoclopramide Major Product Offerings
7.18.4 Omega Laboratories Metoclopramide Sales and Revenue in Global (2017-2022)
7.18.5 Omega Laboratories Key News
7.19 Orion Pharma
7.19.1 Orion Pharma Corporate Summary
7.19.2 Orion Pharma Business Overview
7.19.3 Orion Pharma Metoclopramide Major Product Offerings
7.19.4 Orion Pharma Metoclopramide Sales and Revenue in Global (2017-2022)
7.19.5 Orion Pharma Key News
7.20 Pfizer
7.20.1 Pfizer Corporate Summary
7.20.2 Pfizer Business Overview
7.20.3 Pfizer Metoclopramide Major Product Offerings
7.20.4 Pfizer Metoclopramide Sales and Revenue in Global (2017-2022)
7.20.5 Pfizer Key News
7.21 Wockhardt
7.21.1 Wockhardt Corporate Summary
7.21.2 Wockhardt Business Overview
7.21.3 Wockhardt Metoclopramide Major Product Offerings
7.21.4 Wockhardt Metoclopramide Sales and Revenue in Global (2017-2022)
7.21.5 Wockhardt Key News
7.22 Amneal Pharmaceuticals
7.22.1 Amneal Pharmaceuticals Corporate Summary
7.22.2 Amneal Pharmaceuticals Business Overview
7.22.3 Amneal Pharmaceuticals Metoclopramide Major Product Offerings
7.22.4 Amneal Pharmaceuticals Metoclopramide Sales and Revenue in Global (2017-2022)
7.22.5 Amneal Pharmaceuticals Key News
7.23 Nidda
7.23.1 Nidda Corporate Summary
7.23.2 Nidda Business Overview
7.23.3 Nidda Metoclopramide Major Product Offerings
7.23.4 Nidda Metoclopramide Sales and Revenue in Global (2017-2022)
7.23.5 Nidda Key News
7.24 Ceva Sante Animale
7.24.1 Ceva Sante Animale Corporate Summary
7.24.2 Ceva Sante Animale Business Overview
7.24.3 Ceva Sante Animale Metoclopramide Major Product Offerings
7.24.4 Ceva Sante Animale Metoclopramide Sales and Revenue in Global (2017-2022)
7.24.5 Ceva Sante Animale Key News
8 GLOBAL METOCLOPRAMIDE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Metoclopramide Production Capacity, 2017-2028
8.2 Metoclopramide Production Capacity of Key Manufacturers in Global Market
8.3 Global Metoclopramide Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 METOCLOPRAMIDE SUPPLY CHAIN ANALYSIS
10.1 Metoclopramide Industry Value Chain
10.2 Metoclopramide Upstream Market
10.3 Metoclopramide Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Metoclopramide Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Metoclopramide in Global Market
Table 2. Top Metoclopramide Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Metoclopramide Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Metoclopramide Revenue Share by Companies, 2017-2022
Table 5. Global Metoclopramide Sales by Companies, (K Units), 2017-2022
Table 6. Global Metoclopramide Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Metoclopramide Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Metoclopramide Product Type
Table 9. List of Global Tier 1 Metoclopramide Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Metoclopramide Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Metoclopramide Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Metoclopramide Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Metoclopramide Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Metoclopramide Sales (K Units), 2017-2022
Table 15. By Type - Global Metoclopramide Sales (K Units), 2023-2028
Table 16. By Application – Global Metoclopramide Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Metoclopramide Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Metoclopramide Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Metoclopramide Sales (K Units), 2017-2022
Table 20. By Application - Global Metoclopramide Sales (K Units), 2023-2028
Table 21. By Region – Global Metoclopramide Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Metoclopramide Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Metoclopramide Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Metoclopramide Sales (K Units), 2017-2022
Table 25. By Region - Global Metoclopramide Sales (K Units), 2023-2028
Table 26. By Country - North America Metoclopramide Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Metoclopramide Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Metoclopramide Sales, (K Units), 2017-2022
Table 29. By Country - North America Metoclopramide Sales, (K Units), 2023-2028
Table 30. By Country - Europe Metoclopramide Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Metoclopramide Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Metoclopramide Sales, (K Units), 2017-2022
Table 33. By Country - Europe Metoclopramide Sales, (K Units), 2023-2028
Table 34. By Region - Asia Metoclopramide Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Metoclopramide Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Metoclopramide Sales, (K Units), 2017-2022
Table 37. By Region - Asia Metoclopramide Sales, (K Units), 2023-2028
Table 38. By Country - South America Metoclopramide Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Metoclopramide Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Metoclopramide Sales, (K Units), 2017-2022
Table 41. By Country - South America Metoclopramide Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Metoclopramide Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Metoclopramide Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Metoclopramide Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Metoclopramide Sales, (K Units), 2023-2028
Table 46. Teva Corporate Summary
Table 47. Teva Metoclopramide Product Offerings
Table 48. Teva Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Sanofi Corporate Summary
Table 50. Sanofi Metoclopramide Product Offerings
Table 51. Sanofi Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Astellas Corporate Summary
Table 53. Astellas Metoclopramide Product Offerings
Table 54. Astellas Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Adwya Corporate Summary
Table 56. Adwya Metoclopramide Product Offerings
Table 57. Adwya Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Biofarma Corporate Summary
Table 59. Biofarma Metoclopramide Product Offerings
Table 60. Biofarma Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Apotex Corporate Summary
Table 62. Apotex Metoclopramide Product Offerings
Table 63. Apotex Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Novartis Corporate Summary
Table 65. Novartis Metoclopramide Product Offerings
Table 66. Novartis Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. ASKA Seiyaku Asuka Corporate Summary
Table 68. ASKA Seiyaku Asuka Metoclopramide Product Offerings
Table 69. ASKA Seiyaku Asuka Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Yang Sheng Corporate Summary
Table 71. Yang Sheng Metoclopramide Product Offerings
Table 72. Yang Sheng Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Meda Pharma Corporate Summary
Table 74. Meda Pharma Metoclopramide Product Offerings
Table 75. Meda Pharma Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Johnson and Johnson Corporate Summary
Table 77. Johnson and Johnson Metoclopramide Product Offerings
Table 78. Johnson and Johnson Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. GSK Corporate Summary
Table 80. GSK Metoclopramide Product Offerings
Table 81. GSK Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Alkaloid Pharmaceuticals Corporate Summary
Table 83. Alkaloid Pharmaceuticals Metoclopramide Product Offerings
Table 84. Alkaloid Pharmaceuticals Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Teuto Brasileiro Corporate Summary
Table 86. Teuto Brasileiro Metoclopramide Product Offerings
Table 87. Teuto Brasileiro Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Mylan Corporate Summary
Table 89. Mylan Metoclopramide Product Offerings
Table 90. Mylan Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. EU-Pharma Corporate Summary
Table 92. EU-Pharma Metoclopramide Product Offerings
Table 93. EU-Pharma Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Le Vet Corporate Summary
Table 95. Le Vet Metoclopramide Product Offerings
Table 96. Le Vet Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Omega Laboratories Corporate Summary
Table 98. Omega Laboratories Metoclopramide Product Offerings
Table 99. Omega Laboratories Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Orion Pharma Corporate Summary
Table 101. Orion Pharma Metoclopramide Product Offerings
Table 102. Orion Pharma Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. Pfizer Corporate Summary
Table 104. Pfizer Metoclopramide Product Offerings
Table 105. Pfizer Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 106. Wockhardt Corporate Summary
Table 107. Wockhardt Metoclopramide Product Offerings
Table 108. Wockhardt Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 109. Amneal Pharmaceuticals Corporate Summary
Table 110. Amneal Pharmaceuticals Metoclopramide Product Offerings
Table 111. Amneal Pharmaceuticals Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 112. Nidda Corporate Summary
Table 113. Nidda Metoclopramide Product Offerings
Table 114. Nidda Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 115. Ceva Sante Animale Corporate Summary
Table 116. Ceva Sante Animale Metoclopramide Product Offerings
Table 117. Ceva Sante Animale Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 118. Metoclopramide Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 119. Global Metoclopramide Capacity Market Share of Key Manufacturers, 2020-2022
Table 120. Global Metoclopramide Production by Region, 2017-2022 (K Units)
Table 121. Global Metoclopramide Production by Region, 2023-2028 (K Units)
Table 122. Metoclopramide Market Opportunities & Trends in Global Market
Table 123. Metoclopramide Market Drivers in Global Market
Table 124. Metoclopramide Market Restraints in Global Market
Table 125. Metoclopramide Raw Materials
Table 126. Metoclopramide Raw Materials Suppliers in Global Market
Table 127. Typical Metoclopramide Downstream
Table 128. Metoclopramide Downstream Clients in Global Market
Table 129. Metoclopramide Distributors and Sales Agents in Global Market
Table 1. Key Players of Metoclopramide in Global Market
Table 2. Top Metoclopramide Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Metoclopramide Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Metoclopramide Revenue Share by Companies, 2017-2022
Table 5. Global Metoclopramide Sales by Companies, (K Units), 2017-2022
Table 6. Global Metoclopramide Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Metoclopramide Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Metoclopramide Product Type
Table 9. List of Global Tier 1 Metoclopramide Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Metoclopramide Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Metoclopramide Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Metoclopramide Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Metoclopramide Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Metoclopramide Sales (K Units), 2017-2022
Table 15. By Type - Global Metoclopramide Sales (K Units), 2023-2028
Table 16. By Application – Global Metoclopramide Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Metoclopramide Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Metoclopramide Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Metoclopramide Sales (K Units), 2017-2022
Table 20. By Application - Global Metoclopramide Sales (K Units), 2023-2028
Table 21. By Region – Global Metoclopramide Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Metoclopramide Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Metoclopramide Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Metoclopramide Sales (K Units), 2017-2022
Table 25. By Region - Global Metoclopramide Sales (K Units), 2023-2028
Table 26. By Country - North America Metoclopramide Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Metoclopramide Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Metoclopramide Sales, (K Units), 2017-2022
Table 29. By Country - North America Metoclopramide Sales, (K Units), 2023-2028
Table 30. By Country - Europe Metoclopramide Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Metoclopramide Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Metoclopramide Sales, (K Units), 2017-2022
Table 33. By Country - Europe Metoclopramide Sales, (K Units), 2023-2028
Table 34. By Region - Asia Metoclopramide Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Metoclopramide Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Metoclopramide Sales, (K Units), 2017-2022
Table 37. By Region - Asia Metoclopramide Sales, (K Units), 2023-2028
Table 38. By Country - South America Metoclopramide Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Metoclopramide Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Metoclopramide Sales, (K Units), 2017-2022
Table 41. By Country - South America Metoclopramide Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Metoclopramide Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Metoclopramide Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Metoclopramide Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Metoclopramide Sales, (K Units), 2023-2028
Table 46. Teva Corporate Summary
Table 47. Teva Metoclopramide Product Offerings
Table 48. Teva Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Sanofi Corporate Summary
Table 50. Sanofi Metoclopramide Product Offerings
Table 51. Sanofi Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Astellas Corporate Summary
Table 53. Astellas Metoclopramide Product Offerings
Table 54. Astellas Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Adwya Corporate Summary
Table 56. Adwya Metoclopramide Product Offerings
Table 57. Adwya Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Biofarma Corporate Summary
Table 59. Biofarma Metoclopramide Product Offerings
Table 60. Biofarma Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Apotex Corporate Summary
Table 62. Apotex Metoclopramide Product Offerings
Table 63. Apotex Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Novartis Corporate Summary
Table 65. Novartis Metoclopramide Product Offerings
Table 66. Novartis Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. ASKA Seiyaku Asuka Corporate Summary
Table 68. ASKA Seiyaku Asuka Metoclopramide Product Offerings
Table 69. ASKA Seiyaku Asuka Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Yang Sheng Corporate Summary
Table 71. Yang Sheng Metoclopramide Product Offerings
Table 72. Yang Sheng Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Meda Pharma Corporate Summary
Table 74. Meda Pharma Metoclopramide Product Offerings
Table 75. Meda Pharma Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Johnson and Johnson Corporate Summary
Table 77. Johnson and Johnson Metoclopramide Product Offerings
Table 78. Johnson and Johnson Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. GSK Corporate Summary
Table 80. GSK Metoclopramide Product Offerings
Table 81. GSK Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Alkaloid Pharmaceuticals Corporate Summary
Table 83. Alkaloid Pharmaceuticals Metoclopramide Product Offerings
Table 84. Alkaloid Pharmaceuticals Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Teuto Brasileiro Corporate Summary
Table 86. Teuto Brasileiro Metoclopramide Product Offerings
Table 87. Teuto Brasileiro Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Mylan Corporate Summary
Table 89. Mylan Metoclopramide Product Offerings
Table 90. Mylan Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. EU-Pharma Corporate Summary
Table 92. EU-Pharma Metoclopramide Product Offerings
Table 93. EU-Pharma Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Le Vet Corporate Summary
Table 95. Le Vet Metoclopramide Product Offerings
Table 96. Le Vet Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Omega Laboratories Corporate Summary
Table 98. Omega Laboratories Metoclopramide Product Offerings
Table 99. Omega Laboratories Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Orion Pharma Corporate Summary
Table 101. Orion Pharma Metoclopramide Product Offerings
Table 102. Orion Pharma Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. Pfizer Corporate Summary
Table 104. Pfizer Metoclopramide Product Offerings
Table 105. Pfizer Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 106. Wockhardt Corporate Summary
Table 107. Wockhardt Metoclopramide Product Offerings
Table 108. Wockhardt Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 109. Amneal Pharmaceuticals Corporate Summary
Table 110. Amneal Pharmaceuticals Metoclopramide Product Offerings
Table 111. Amneal Pharmaceuticals Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 112. Nidda Corporate Summary
Table 113. Nidda Metoclopramide Product Offerings
Table 114. Nidda Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 115. Ceva Sante Animale Corporate Summary
Table 116. Ceva Sante Animale Metoclopramide Product Offerings
Table 117. Ceva Sante Animale Metoclopramide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 118. Metoclopramide Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 119. Global Metoclopramide Capacity Market Share of Key Manufacturers, 2020-2022
Table 120. Global Metoclopramide Production by Region, 2017-2022 (K Units)
Table 121. Global Metoclopramide Production by Region, 2023-2028 (K Units)
Table 122. Metoclopramide Market Opportunities & Trends in Global Market
Table 123. Metoclopramide Market Drivers in Global Market
Table 124. Metoclopramide Market Restraints in Global Market
Table 125. Metoclopramide Raw Materials
Table 126. Metoclopramide Raw Materials Suppliers in Global Market
Table 127. Typical Metoclopramide Downstream
Table 128. Metoclopramide Downstream Clients in Global Market
Table 129. Metoclopramide Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Metoclopramide Segment by Type
Figure 2. Metoclopramide Segment by Application
Figure 3. Global Metoclopramide Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Metoclopramide Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Metoclopramide Revenue, 2017-2028 (US$, Mn)
Figure 7. Metoclopramide Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Metoclopramide Revenue in 2021
Figure 9. By Type - Global Metoclopramide Sales Market Share, 2017-2028
Figure 10. By Type - Global Metoclopramide Revenue Market Share, 2017-2028
Figure 11. By Type - Global Metoclopramide Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Metoclopramide Sales Market Share, 2017-2028
Figure 13. By Application - Global Metoclopramide Revenue Market Share, 2017-2028
Figure 14. By Application - Global Metoclopramide Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Metoclopramide Sales Market Share, 2017-2028
Figure 16. By Region - Global Metoclopramide Revenue Market Share, 2017-2028
Figure 17. By Country - North America Metoclopramide Revenue Market Share, 2017-2028
Figure 18. By Country - North America Metoclopramide Sales Market Share, 2017-2028
Figure 19. US Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Metoclopramide Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Metoclopramide Sales Market Share, 2017-2028
Figure 24. Germany Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 25. France Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Metoclopramide Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Metoclopramide Sales Market Share, 2017-2028
Figure 33. China Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 37. India Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Metoclopramide Revenue Market Share, 2017-2028
Figure 39. By Country - South America Metoclopramide Sales Market Share, 2017-2028
Figure 40. Brazil Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Metoclopramide Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Metoclopramide Sales Market Share, 2017-2028
Figure 44. Turkey Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 48. Global Metoclopramide Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Metoclopramide by Region, 2021 VS 2028
Figure 50. Metoclopramide Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Metoclopramide Segment by Type
Figure 2. Metoclopramide Segment by Application
Figure 3. Global Metoclopramide Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Metoclopramide Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Metoclopramide Revenue, 2017-2028 (US$, Mn)
Figure 7. Metoclopramide Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Metoclopramide Revenue in 2021
Figure 9. By Type - Global Metoclopramide Sales Market Share, 2017-2028
Figure 10. By Type - Global Metoclopramide Revenue Market Share, 2017-2028
Figure 11. By Type - Global Metoclopramide Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Metoclopramide Sales Market Share, 2017-2028
Figure 13. By Application - Global Metoclopramide Revenue Market Share, 2017-2028
Figure 14. By Application - Global Metoclopramide Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Metoclopramide Sales Market Share, 2017-2028
Figure 16. By Region - Global Metoclopramide Revenue Market Share, 2017-2028
Figure 17. By Country - North America Metoclopramide Revenue Market Share, 2017-2028
Figure 18. By Country - North America Metoclopramide Sales Market Share, 2017-2028
Figure 19. US Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Metoclopramide Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Metoclopramide Sales Market Share, 2017-2028
Figure 24. Germany Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 25. France Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Metoclopramide Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Metoclopramide Sales Market Share, 2017-2028
Figure 33. China Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 37. India Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Metoclopramide Revenue Market Share, 2017-2028
Figure 39. By Country - South America Metoclopramide Sales Market Share, 2017-2028
Figure 40. Brazil Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Metoclopramide Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Metoclopramide Sales Market Share, 2017-2028
Figure 44. Turkey Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Metoclopramide Revenue, (US$, Mn), 2017-2028
Figure 48. Global Metoclopramide Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Metoclopramide by Region, 2021 VS 2028
Figure 50. Metoclopramide Industry Value Chain
Figure 51. Marketing Channels
